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Obesity and the associated state of subchronic inflammation are risk factors for numerous pathologies,
including carcinogenesis. Recently, Schulz et al. (2014) demonstrated that high-fat diet-induced intestinal
dysbiosis promotes cancer development in K-rasG12Dintmice without inducing obesity or mucosal inflamma-
tion, positioning microbial activities as a central component of diet-induced carcinogenesis.The intestinal tract is a dynamic milieu
where 100 trillion bacteria interact daily
with lumenal contents, intestinal epithelial
cells, and underlying immune cells. The
interplay between these factors repre-
sents a key balance point between ho-
meostasis and disease, as aberration in
any of their activities can lead to inflam-
mation and even cancer (Irraza´bal et al.,
2014). With its impact on host and mi-
crobes, nutrition represents an important
factor able to influence the homeostatic
circuitry present in the gut. For example,
diet-induced obesity has been associ-
ated with a 30%–70% increased risk
of colon cancer in men (Bardou et al.,
2013) and is linked to an altered intestinal
microbiota (Ley et al., 2006). However, the
contribution of obesity-associated low-
grade inflammation in diet-induced carci-
nogenesis and the role of microbes in this
pathological cascade are unclear.
A recent publication by Schulz et al.
contributes an important piece to this
puzzle by demonstrating that the dys-
biosis caused by consumption of a
lard-based high-fat diet (HFD) enhances
adenocarcinoma development and
metastasis in K-rasG12Dint mice, withoutpromoting overt inflammation or causing
obesity (Schulz et al., 2014). This observa-
tion suggests that HFD-induced cancer is
not preceded by obesity or inflammation,
but rather depends on microbial activity.
The cancer-promoting microbiota seems
to depend on both the HFD and host
genetics. Indeed, the authors showed
that K-ras oncogene activation results in
decreased Paneth cell function (cryptdin
expression), while HFD attenuates mucin
expression (Muc2), two components crit-
ical in controlling intestinal microbial load
and geographical distribution. Therefore,
these changes likely act in concert to pro-
mote the progression from low-level
dysplasia in regular chow-fed mice to
small bowel carcinogenesis and metas-
tasis in mice consuming HFD.
The provocative observation that K-
rasG12Dint mice fed HFD developed can-
cer while remaining significantly leaner,
without evidence of metabolic syndrome,
challenges the dogmatic sequence of diet
inducing obesity and the subsequent
inflammation leading to cancer. Indeed,
the authors were able to transfer the
carcinogenic phenotype by fecal trans-
plants, demonstrating the primary role ofbacteria in cancer development in these
mice. However, this phenotype is only
seen in fecal-transplanted K-rasG12Dint
mice, not in transplanted LSL-K-rasG12D/
+ littermate controls, supporting the
notion that cancer arises from an interac-
tion between genes and the environment
(bacteria). Importantly, while inducing
carcinogenesis, the microbiota transfer
did not promote obesity or insulin desen-
sitization (Schulz et al., 2014). Therefore,
changes in microbial factors drive cancer
development in these mice rather than di-
etary differences, body mass index, or
low-grade intestinal inflammation. As
few models are able to dissociate these
consequences of HFD, this study pro-
vides a revelation regarding the interplay
between environment factors such as
nutrition and the path to carcinogenesis.
While there is likely still a role for direct di-
etary effects on other aspects of cancer, it
is clear that microbiota play a critical,
central role in absorbing the impact of
various dietary insults and passing the
consequences on to the host (Figure 1).
Interestingly, short-chain fatty acid pro-
duction by the microbiota was impaired in
HFD-fed K-rasG12Dint mice, and butyrateDecember 2, 2014 ª2014 Elsevier Inc. 937
Muc2
Figure 1. High-Fat Diet-Induced Dysbiosis
Promotes Cancer Development in
K-rasG12Dint Mice
Decreased cryptdin expression caused by K-ras
oncogene activation, coupled with decreased
Muc2 expression from high-fat diet consumption,
leads to a distinct shift in the microbiota. This dys-
biosis is characterized by decreased butyrate pro-
duction and leads to increased cancer occurrence.
MyD88 signaling is implicated in the disease
progression, perhaps by both promoting a prolif-
erative signal and influencing the population of
butyrate-producing bacteria, as this short-chain
fatty acid prevents proliferation of tumor-initiated
epithelial cells.
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esis in this model by normalizing recruit-
ment of dendritic cells to the gut (Schulz
et al., 2014). Butyrate administration
was also found to be protective in the
Apcmin/+mousemodel of intestinal cancer
(Singh et al., 2014), but detrimental in
Apcmin/+Msh2/ mice (Belcheva et al.,
2014). In the latter model, a low-carbohy-
drate diet was associated with decreased
abundance of butyrate-producing bacte-
ria and reduced intestinal colonic polyps.
This highlights the complex interplay be-
tween nutrition-derived microbial metab-
olites such as butyrate and host genetic
status.
Additionally, the authors implicated
host innate recognition of bacteria in
cancer development in K-rasG12Dint mice,
since ablation of Myd88 completely
blocked tumor formation. These findings
suggest that MyD88 may transmit a
carcinogenic signal from the dysbiotic
microbiota, although the nature of this
signal has not been defined. However,938 Cell Metabolism 20, December 2, 2014 ªsince Schulz et al. reported that MyD88
deletion changes microbial composition
in K-rasG12Dint; Myd88/ mice, including
enhancedabundanceofbutyrate-produc-
ingRuminococcaceae, it is likely that host-
derived MyD88 signaling also influences
the microbiome. To expand on these re-
sults, it would have been interesting to
measure levels of SCFA in K-rasG12Dint;
Myd88/ mice and to expose these
mice toa low-fiberdiet to reduce theability
of the microbiota to produce butyrate.
In summary, Schulz et al. have exposed
an intriguing relationship between the in-
testinal microbiota, diet, and cancer
development. While small bowel cancers
are rare (comprising only 1%–2% of all
gastrointestinal cancers), this model pro-
vides evidence for a causative role of
diet-induced microbial dysbiosis in carci-
nogenesis. Although inflammation repre-
sents an important environmental condi-
tion fostering the capacity of microbes
to induce carcinogenesis (Arthur et al.,
2014; Elinav et al., 2013), Schulz et al.
demonstrated that HFD may alternatively
alter microbial activities leading to tumor-
igenesis in K-rasG12Dint mice. It will be
important to extend the observation
made with the K-rasG12Dint mice to more
robust colorectal cancer models. For
example, HFD also enhances tumor for-
mation in Apcmin/+ mice (Wasan et al.,
1997), but it is unknown if this is directly
due to obesity.
The findings reported by Schulz et al.
not only shift our expectations of how
diet can cause cancer, but also opens up
many intriguing questions. Is the obesity-
independent, cancer-promoting activity
of the K-rasG12Dint microbiota selective to
this particular host mutation? Or is this a
common feature of diet-induced carcino-
genesis? Since cryptdin and mucin
expression were only measured at the
experimental endpoint of 22 weeks, do
these host alterations result from or lead
to the development of dysbiosis? In addi-
tion, although the intestinal epithelium is
hyperplastic in K-rasG12Dint mice fed a
normal diet, carcinogenesis developed
only in the duodenum of HFD-exposed
mice, suggesting a geographical impact
of bacteria. This is reminiscent of the loca-
tion-specific tumors observed in mice ex-
pressing two oncogenic transgenes
throughout their intestines (cytomegalo-
virus chemokine receptorUS28andhepa-
rin-binding EGF-like growth factor) that2014 Elsevier Inc.developed serrated polyps only in the
cecum. These mice showed tumor-spe-
cific microbial dysbiosis and decreased
barrier function, which was associated
with bacterial invasion and cancer promo-
tion (Bongers et al., 2014). Therefore, it
would be important to specifically assess
the microbiome in mucosal-associated
tumors in HFD K-rasG12Dint mice com-
pared to similar locations in regular diet-
fed K-rasG12Dint mice.
Understanding the sequence of events
leading to dysbiosis and cancer is critical
for the development of potential thera-
pies. In addition, further studies will be
needed to unveil not just the composition
of nutrition-dependent cancer-promoting
microbiota but also its functional impact
using transcriptomic and metabolomic
approaches. This kind of detailed analysis
could ultimately lead to personalized ther-
apies where information on host genetic
and microbial activities could be merged
to define the optimal therapeutic regimen
matching a defined cancer type and
individual.REFERENCES
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